Dr. Agarwal'S Health Care Profile
Key Indicators
- Authorised Capital ₹ 90.00 Cr
- Paid Up Capital ₹ 30.84 Cr
- Company Age 14 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 467.01 Cr
- Satisfied Charges ₹ 475.56 Cr
- Revenue Growth 43.39%
- Profit Growth -24.56%
- Ebitda 38.81%
- Net Worth 118.54%
- Total Assets 57.61%
About Dr. Agarwal'S Health Care
Dr. Agarwal's Health Care Limited (DAHCL) is a leading Public Limited Indian Non-Government Company incorporated in India on 19 April 2010 and has a history of 14 years and ten months. Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 90.00 Cr and a paid-up capital of Rs 30.84 Cr.
The company currently has active open charges totaling ₹467.01 Cr. The company has closed loans amounting to ₹475.56 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Dr. Agarwal's Health Care Limited India are Adil Agarwal as Ceo, A Thanikainathan as Company Secretary, and Jagannathan Venkat as Cfo. Nachiket Mor, Amar Agarwal, Ranjan Pai, and Seven other members serve as directors at the Company.
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U85100TN2010PLC075403
- Company No.
075403
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
19 Apr 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
What products or services does Dr. Agarwal's Health Care Limited offer?
Dr. Agarwal'S Health Care Limited offers a wide range of products and services, including Medical Surgery & Treatment Centres, Medical Treatment Services.
Who are the key members and board of directors at Dr. Agarwal'S Health Care?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Adil Agarwal  | CEO | 01-May-2016 | Current |
| A Thanikainathan | Company Secretary | 03-Sep-2019 | Current |
| Jagannathan Venkat | CFO | 26-Sep-2024 | Current |
Board Members (10)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Balakrishnan Venkatraman | Director | 03-Sep-2019 | Current |
| Sanjay Anand | Director | 30-Sep-2016 | Current |
| Anosh Agarwal | Whole-Time Director | 30-Jan-2014 | Current |
| Ankur Thadani | Nominee Director | 05-May-2022 | Current |
| Adil Agarwal | Whole-Time Director and Ceo | 01-May-2016 | Current |
| Nachiket Mor | Director | 17-Sep-2024 | Current |
Financial Performance of Dr. Agarwal'S Health Care.
Dr. Agarwal'S Health Care Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 43.39% increase. The company also saw a substantial fall in profitability, with a 24.56% decrease in profit. The company's net worth Soared by an impressive increase of 118.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr. Agarwal'S Health Care?
In 2024, Dr. Agarwal'S Health Care had a promoter holding of 31.69% and a public holding of 68.31%. The company had 3 Subsidiaries and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Uber9 Business Process Services Private LimitedAnosh Agarwal is a mutual person
Immuneel Therapeutics Private LimitedRanjan Pai is a mutual person
Billionloans Financial Services Private LimitedBalakrishnan Venkatraman is a mutual person
Manipal Health Enterprises Private LimitedRanjan Pai and Ved Kalanoria are mutual person
Maatrum Technologies And Legal Ventures Private LimitedAdil Agarwal and Anosh Agarwal are mutual person
Elisar Life Sciences Private LimitedAnosh Agarwal is a mutual person
Charges (Loans)
₹467.01 Cr
₹475.56 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 172.50 Cr
- Others : 167.00 Cr
- Axis Bank Limited : 77.51 Cr
- Yes Bank Limited : 50.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 May 2023 | Yes Bank Limited | ₹50.00 Cr | Open |
| 16 May 2023 | Others | ₹165.00 Cr | Open |
| 16 May 2023 | Others | ₹2.00 Cr | Open |
| 10 Oct 2022 | Axis Bank Limited | ₹77.51 Cr | Open |
| 02 Dec 2010 | Hdfc Bank Limited | ₹172.50 Cr | Open |
How Many Employees Work at Dr. Agarwal'S Health Care?
Dr. Agarwal'S Health Care has a workforce of 2971 employees as of Jan 21, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr. Agarwal'S Health Care, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr. Agarwal'S Health Care's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
